About: Cost-effectiveness of pravastatin in the secondary prevention of CAD in men varied with the risk profile of the patient

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Cost-effectiveness of pravastatin in the secondary prevention of CAD in men varied with the risk profile of the patient Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_2/w
Subject	Economics
Title	Cost-effectiveness of pravastatin in the secondary prevention of CAD in men varied with the risk profile of the patient
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_2/B3555EDB43C238C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebm/1997/volume_2/issue_2/B3555EDB43C238C5E053120B220A16A6/m/web
Abstract	AshrafTHayJWPittB. Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease. Am J Cardiol. 1996 Aug 15;78:409-14.
article type	other
publisher identifier	ebmed263
is part of this journal	Evidence Based Medicine

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata